Skip to content

Apoteek Bilcke: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apoteek Bilcke

BE 0440.598.447
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€40,942
2024 · -€58,958+€18,017
Equity
€903,784
2024 · €944,726-€40,942
Cash
€241,458
2024 · €254,473-€13,015
Balance sheet total
€1.1m
2024 · €1.1m+€34,123

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€34,391

    up €34,391 (+6.9%), from €497,696 to €532,088

    of which Trade receivables: +€77,023

  • Stocks and contracts +€15,767

    up €15,767 (+5.0%), from €315,315 to €331,082

  • Cash -€13,015

    down €13,015 (-5.1%), from €254,473 to €241,458

    mainly Net result for the year (-€40,942) and Receivables within one year (-€34,391)

Equity and liabilities
  • Trade debts +€74,724

    up €74,724 (+74.4%), from €100,445 to €175,170

  • Profit (loss) carried forward -€40,942

    down €40,942 (-61.5%), from -€66,539 to -€107,480

Income statement
  • Staff costs -€35,313

    down €35,313 (-8.8%), from €401,571 to €366,257

  • Gross operating margin -€16,690

    down €16,690 (-4.8%), from €350,586 to €333,896

  • Depreciation +€5,052

    up €5,052 (+411%), from €1,230 to €6,282

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€58,958
Gross operating margin -€16,690
Staff costs +€35,313
Depreciation -€5,052
Other operating charges +€3,119
Other operating items +€2,165
Financial income -€497
Financial charges -€342
Result 2025 -€40,942
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€11,280
Investment -€1,735
Financing €0
Cash 2024 €254,473
Net result for the year -€40,942
Depreciation +€6,282
Stocks and contracts -€15,767
Receivables within one year -€34,391
Deferred charges and accrued income -€1,527
Trade debts +€74,724
Tax, wage and social debts +€1,171
Accrued charges and deferred income -€831
Investment in fixed assets (net) -€1,735
Cash 2025 €241,458
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,099,956 €1,134,079 +€34,123 +3.1%
Fixed assets 21/28 €30,591 €26,044 -€4,547 -14.9%
Tangible fixed assets 22/27 €30,591 €26,044 -€4,547 -14.9%
Land and buildings 22 €20,969 €20,242 -€727 -3.5%
Plant, machinery and equipment 23 €9,622 €5,802 -€3,820 -39.7%
Current assets 29/58 €1,069,365 €1,108,035 +€38,670 +3.6%
Stocks and contracts in progress 3 €315,315 €331,082 +€15,767 +5.0%
Stocks 30/36 €315,315 €331,082 +€15,767 +5.0%
Amounts receivable within one year 40/41 €497,696 €532,088 +€34,391 +6.9%
Trade receivables 40 €88,552 €165,575 +€77,023 +87.0%
Other amounts receivable 41 €409,144 €366,513 -€42,631 -10.4%
Cash at bank and in hand 54/58 €254,473 €241,458 -€13,015 -5.1%
Deferred charges and accrued income 490/1 €1,881 €3,407 +€1,527 +81.2%
Total equity and liabilities 10/49 €1,099,956 €1,134,079 +€34,123 +3.1%
Equity 10/15 €944,726 €903,784 -€40,942 -4.3%
Contributions 10/11 €92,968 €92,968 = 0.0%
Reserves 13 €918,297 €918,297 = 0.0%
Distributable reserves 133 €918,297 €918,297 = 0.0%
Profit (loss) carried forward 14 -€66,539 -€107,480 -€40,942 -61.5%
Amounts payable 17/49 €155,230 €230,294 +€75,064 +48.4%
Amounts payable within one year 42/48 €151,892 €227,788 +€75,896 +50.0%
Trade debts 44 €100,445 €175,170 +€74,724 +74.4%
Suppliers 440/4 €100,445 €175,170 +€74,724 +74.4%
Taxes, remuneration and social security 45 €51,447 €52,618 +€1,171 +2.3%
Taxes 450/3 - €4 +€4
Remuneration and social security 454/9 €51,447 €52,614 +€1,167 +2.3%
Accrued charges and deferred income 492/3 €3,338 €2,507 -€831 -24.9%
Remuneration, social security and pensions 62 €401,571 €366,257 -€35,313 -8.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,230 €6,282 +€5,052 +411%
Other operating charges 640/8 €4,193 €1,073 -€3,119 -74.4%
Non-recurring operating charges 66A €2,165 - -€2,165
Gross operating margin 9900 €350,586 €333,896 -€16,690 -4.8%
Operating profit (loss) 9901 -€58,572 -€39,717 +€18,855 +32.2%
Financial income 75/76B €2,174 €1,677 -€497 -22.8%
Recurring financial income 75 €2,174 €1,677 -€497 -22.8%
Financial charges 65/66B €2,560 €2,902 +€342 +13.4%
Recurring financial charges 65 €2,560 €2,902 +€342 +13.4%
Profit (loss) for the period before taxes 9903 -€58,958 -€40,942 +€18,017 +30.6%
Profit (loss) for the period 9904 -€58,958 -€40,942 +€18,017 +30.6%
Profit (loss) for the period to be appropriated 9905 -€58,958 -€40,942 +€18,017 +30.6%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.